IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…
Matched conditions: IMMUNOGENICITY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 12:45 UTC
-
Mpox vaccine trial for babies launches in congo: could half a dose be enough?
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo. Half of the children receive a full dose and half receive a half dose, both given as two shots 28 days apart. The go…
Matched conditions: IMMUNOGENICITY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:47 UTC
-
BREATH study tracks biologic drug effects in severe asthma
Knowledge-focused OngoingThis study observes 100 people with severe asthma who are taking biologic drugs. Researchers measure how the body's immune system reacts to the drug and whether that affects how well the treatment works. The goal is to better understand drug effectiveness and safety over time.
Matched conditions: IMMUNOGENICITY
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 12:54 UTC